Methyl-Life®: About Us
Methyl-Life® Medical, Nutritional, Genetic & Wellness Team
Our Qualified Medical Writers & Reviewers
Katie Stone
Naturopath (BNatMed)
Katie is a qualified Naturopath (BNatMed) and freelance writer from New Zealand. She specializes in all things health and wellness, particularly dietary supplements and nutrition. Katie is also a dedicated runner and has completed more half-marathons than she can count!
Dr. Conor Sheehy
PharmD, BCPS
Conor Sheehy, PharmD, BCPS, is a board-certified pharmacist who earned his PharmD from the University of Washington. He specializes in the management of patients with metabolic diseases, including diabetes mellitus. He is also a professional medical writer who believes in providing people with accurate and easy to understand information.
Dr. Sheehy believes that medical information has the highest potential to improve people’s lives when it is accessible. His other clinical interests include anticoagulation, oncology, cardiology, and psychiatry.
Dr. Sheehy believes that medical information has the highest potential to improve people’s lives when it is accessible. His other clinical interests include anticoagulation, oncology, cardiology, and psychiatry.
Dr. Nare Simonyan
PhD Pharmaceutical Science
Nare Simonyan has more than 10 years of experience as a pharmaceutical scientist, medical writer, and science writer. She received her pharmaceutical master's degree at Yerevan State University and her Ph.D. at the Institute of Pharmacy in Armenia. She has experience in both regulatory affairs and clinical trials.
Nare enjoys to read new and emerging scientific article and the results of cutting-edge clinical trials.
Nare enjoys to read new and emerging scientific article and the results of cutting-edge clinical trials.
Kari Asadorian
BSN, RN
Kari Asadorian earned her Bachelor of Science in Nursing (BSN) from The Ohio State University and is a licensed Registered Nurse (RN). She has worked in numerous disciplines – rehabilitation, neurology, orthopedics, psychiatry, geriatrics and pediatrics. She also earned an MBA in Marketing (University of Washington).
She is enthusiastic about wellness, empowering and educating individuals about their health and is very interested in the mind-body connection.
She is enthusiastic about wellness, empowering and educating individuals about their health and is very interested in the mind-body connection.
Dr. Ana Luiza
PhD is in Psychobiology
Dr. Ana Luiza is passionate about Science, Nature, and Biotechnology. Her goal is to have an impact on people’s health and quality of life. She is a professor at Oswaldo Cruz College and a Biologist. Her PhD is in Psychobiology (Sleep Sciences) and her specialty is in Biotechnology (Federal University of São Paulo, Brazil).
Julia-Carolin Zeng
MA in Linguistics and Cultural Anthropology
Julia is an international SEO consultant and reviews all content on the website for relevance and readability for a non-medical audience. She is also a digital nomad and never long in one place. When she’s not at her laptop, she is probably surfing or learning a language.
Dr. Madeeha Malik
Postdoctoral Fellowship, School of Pharmacy, Faculty of Health Sciences, North-West University, Potchefstroom Campus, South AfricaPhD, Pharmacy Practice, Universiti Sains Malaysia, Malaysia
Dr. Madeeha Malik is an internationally recognized health systems and implementation scientist, clinical research leader, and evidence-generation expert with extensive experience in designing, leading and translating research into policy and practice. Her work spans clinical research, implementation science, health systems strengthening, health economics and outcomes research, digital health, women's health, menstrual health, public health and regulatory science.
Over the course of her career, she has established a distinguished research portfolio comprising 135+ peer-reviewed publications, 10+ competitive research grants, led or supported 10+ clinical trials and supervised 70+ postgraduate researchers, while building multidisciplinary research collaborations across more than ten countries. Her scholarly contributions have generated over 1,200 citations, with an H-index of 17 and i10-index of 35.
Her research expertise includes health systems strengthening, implementation research, monitoring and evaluation, health information systems, digital health, health technology assessment, real-world evidence, pharmacovigilance, health economics and outcomes research, regulatory science and community-based health interventions. She has led qualitative, quantitative, mixed-methods and implementation studies aimed at improving healthcare delivery, informing policy decisions, and strengthening institutional capacity in low and middle income countries.
Professor Malik has served as Principal Investigator, Project Lead, and Technical Consultant on numerous national and international research initiatives funded by organizations including the Global Action to End Smoking, EuroQol Research Foundation, PSI Europe, Foundation for a Smoke-Free World, DAI Pakistan and Evidence Action. Her work has included randomized clinical trials, health valuation studies, implementation research, antimicrobial resistance surveillance, health policy evaluations, menstrual health research and behavioral health studies.
As a clinical research expert, she has contributed to the development and oversight of clinical trial protocols, multicenter clinical studies, real-world evidence programs, and regulatory research projects. Her consultancy portfolio includes collaborations with the Drug Regulatory Authority of Pakistan (DRAP), Ministry of National Health Services, Occlutech GmbH, Global Health Consortium UK, Methyl-Life® USA and international academic and research institutions.
Her research has significantly advanced evidence generation in women's health and menstrual health, including studies on menstrual health practices, reproductive health, gender equity, women's economic empowerment, and adolescent health. Through her leadership of Fempure and associated research initiatives, she has integrated scientific evidence with community-based interventions, product innovation, and policy advocacy to improve health outcomes for women and girls across Pakistan.
Dr. Malik currently serves as a Technical Member of the Pharmacovigilance Risk Assessment Committee of the Drug Regulatory Authority of Pakistan (DRAP) and has held several national and international scientific leadership roles and expert membership of international health outcomes and research working groups.
Over the course of her career, she has established a distinguished research portfolio comprising 135+ peer-reviewed publications, 10+ competitive research grants, led or supported 10+ clinical trials and supervised 70+ postgraduate researchers, while building multidisciplinary research collaborations across more than ten countries. Her scholarly contributions have generated over 1,200 citations, with an H-index of 17 and i10-index of 35.
Her research expertise includes health systems strengthening, implementation research, monitoring and evaluation, health information systems, digital health, health technology assessment, real-world evidence, pharmacovigilance, health economics and outcomes research, regulatory science and community-based health interventions. She has led qualitative, quantitative, mixed-methods and implementation studies aimed at improving healthcare delivery, informing policy decisions, and strengthening institutional capacity in low and middle income countries.
Professor Malik has served as Principal Investigator, Project Lead, and Technical Consultant on numerous national and international research initiatives funded by organizations including the Global Action to End Smoking, EuroQol Research Foundation, PSI Europe, Foundation for a Smoke-Free World, DAI Pakistan and Evidence Action. Her work has included randomized clinical trials, health valuation studies, implementation research, antimicrobial resistance surveillance, health policy evaluations, menstrual health research and behavioral health studies.
As a clinical research expert, she has contributed to the development and oversight of clinical trial protocols, multicenter clinical studies, real-world evidence programs, and regulatory research projects. Her consultancy portfolio includes collaborations with the Drug Regulatory Authority of Pakistan (DRAP), Ministry of National Health Services, Occlutech GmbH, Global Health Consortium UK, Methyl-Life® USA and international academic and research institutions.
Her research has significantly advanced evidence generation in women's health and menstrual health, including studies on menstrual health practices, reproductive health, gender equity, women's economic empowerment, and adolescent health. Through her leadership of Fempure and associated research initiatives, she has integrated scientific evidence with community-based interventions, product innovation, and policy advocacy to improve health outcomes for women and girls across Pakistan.
Dr. Malik currently serves as a Technical Member of the Pharmacovigilance Risk Assessment Committee of the Drug Regulatory Authority of Pakistan (DRAP) and has held several national and international scientific leadership roles and expert membership of international health outcomes and research working groups.
